4:55 PM
 | 
Mar 23, 2010
 |  BC Extra  |  Top Story

Oncothyreon falls on Stimuvax hold

Oncothyreon Inc. (NASDAQ:ONTY) lost $1.29 (27%) to $3.49 on Tuesday after FDA placed a clinical hold on Stimuvax due to a case of encephalitis observed in a multiple...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >